Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune Modulation During Treatment with Enzalutamide Alone or with Radium-223 in Patients with Castration Resistant Prostate Cancer. | Cancers (Basel) | 2025 | 40427227 | PubTator, text mining | PubMed |
| Increased expression of membrane-bound TGF-β1, GITR, and GITR ligand in patients with autoimmune thyroid disease. | Immunol Lett | 2025 | 40412445 | PubTator, text mining | PubMed |
| Correction to "Expression of HHLA2, TMIGD2, and GITR in Salivary Gland Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma". | J Oral Pathol Med | 2025 | 40400045 | PubTator, text mining | PubMed |
| Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trial. | J Immunother Cancer | 2025 | 40389374 | PubTator, text mining | PubMed |
| The NF-κB signaling network in the life of T cells. | Front Immunol | 2025 | 40370445 | PubTator, text mining | PubMed |
| Based on Soluble Immune Checkpoints Constructing a Random Survival Forest Model to Predict the Prognosis of Hepatitis B Virus-Associated Hepatocellular Carcinoma. | Onco Targets Ther | 2025 | 40276780 | PubTator, text mining | PubMed |
| Engineered Hollow Nanocomplex Combining Photothermal and Antioxidant Strategies for Targeted Tregs Depletion and Potent Immune Activation in Tumor Immunotherapy. | Adv Healthc Mater | 2025 | 40109122 | PubTator, text mining | PubMed |
| Subtype cluster analysis unveiled the correlation between m6A- and cuproptosis-related lncRNAs and the prognosis, immune microenvironment, and treatment sensitivity of esophageal cancer. | Front Immunol | 2025 | 40034693 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of Key Genes Associated with Resistance to the Combination of Bevacizumab and Pemetrexed Chemotherapy in Non-small Cell Lung Cancer. | Recent Pat Anticancer Drug Discov | 2025 | 39945271 | PubTator, text mining | PubMed |
| Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells. | Oncotarget | 2025 | 39832302 | PubTator, text mining | PubMed |
| Activated CD27+PD-1+ CD8 T Cells and CD4 T Regulatory Cells Dominate the Tumor Microenvironment in Refractory Celiac Disease Type II. | Gastro Hep Adv | 2025 | 39802487 | PubTator, text mining | PubMed |
| Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease. | Cancer Immunol Immunother | 2025 | 39751916 | PubTator, text mining | PubMed |
| TNF/TNFR Superfamily Members in Costimulation of T Cell Responses-Revisited. | Annu Rev Immunol | 2025 | 39745933 | PubTator, text mining | PubMed |
| Lung Cancer-Intrinsic SOX2 Expression Mediates Resistance to Checkpoint Blockade Therapy by Inducing Treg-Dependent CD8+ T-cell Exclusion. | Cancer Immunol Res | 2025 | 39745382 | PubTator, text mining | PubMed |
| Deep phenotyping of T regulatory cells in psoriatic arthritis highlights targetable mechanisms of disease. | J Biol Chem | 2025 | 39662827 | PubTator, text mining | PubMed |
5-Aza-2'-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD4 T cells. | Neoplasia | 2025 | 39608124 | PubTator, text mining | PubMed |
| Soluble Immune Checkpoints Associated With Disease Activity and Treatment Response in GD and TED. | J Clin Endocrinol Metab | 2025 | 39475457 | PubTator, text mining | PubMed |
| Differences in Co-Expression of T Cell Co-Inhibitory and Co-Stimulatory Molecules with PD-1 Across Different Human Cancers. | J Oncol Res Ther | 2024 | 40083977 | PubTator, text mining | PubMed |
| Construction of a prognostic survival model with tumor immune-related genes for breast cancer. | Transl Cancer Res | 2024 | 39816565 | PubTator, text mining | PubMed |
| Correction to "Genetic and pharmacological inhibition of GITR-GITRL interaction reduces chronic lung injury induced by bleomycin instillation". | FASEB J | 2024 | 39604141 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=7